What has this Vitamin D API maker to offer beyond Covid opportunity?

Trading Calls - Equity F&O

Fermenta Biotech’s near-term growth for the Human Vitamin D3 volume is contingent on commissioning of the Dahej plant in the current quarter

Anubhav Sahu